445 results on '"Aikawa, Naoki"'
Search Results
152. Preoperative and postoperative management of patiensts with acute abdomen.
- Author
-
AIKAWA, Naoki, primary
- Published
- 1988
- Full Text
- View/download PDF
153. Clinical analysis of multiple organ failure in burned patients
- Author
-
Aikawa, Naoki, primary, Shinozawa, Yotaro, additional, Ishibiki, Kyuya, additional, Abe, Osahiko, additional, Yamamoto, Shuzo, additional, Motegi, Masahiro, additional, Yoshii, Hiroshi, additional, and Sudoh, Masahiko, additional
- Published
- 1987
- Full Text
- View/download PDF
154. Changes in cell-mediated immunity and tumour growth after thermal injury
- Author
-
Ikeuchi, Shunji, primary, Aikawa, Naoki, additional, Okuda, Makoto, additional, Ishibiki, Kyuya, additional, and Abe, Osahiko, additional
- Published
- 1981
- Full Text
- View/download PDF
155. Postoperative Infections in the Elderly Patients
- Author
-
AIKAWA, NAOKI, primary, TAKAHASHI, TAKAYUKI, additional, ISHIBIKI, KYUYA, additional, and ABE, OSAHIKO, additional
- Published
- 1987
- Full Text
- View/download PDF
156. Pulmonary artery catheterization and thermodilution cardiac output determination in the management of critically burned patients
- Author
-
Aikawa, Naoki, primary, Martyn, J.A.Jeevendra, additional, and Burke, John F., additional
- Published
- 1978
- Full Text
- View/download PDF
157. The Clinical Efficacy of Antithrombin III Concentrate in Infections Complicated by DIC
- Author
-
KOBAYASHI, Hiroyuki, primary, KAWAI, Shin, additional, OSHITANI, Hiroshi, additional, TAMAKUMA, Shoetsu, additional, HAYASAKA, Hiroshi, additional, AKIYAMA, Morio, additional, NAKAMURA, Takashi, additional, HASHIMOTO, Ikuo, additional, SAWADA, Yasuo, additional, TAKEBE, Kazuo, additional, OKAMOTO, Katsuhiro, additional, TAKAHASHI, Shuichi, additional, MASUDA, Mitsuo, additional, TAKEDA, Hajimu, additional, YAMASAKU, Fusanosuke, additional, SUZUKI, Yasutoshi, additional, KATSU, Masataka, additional, HAYASHI, Izumi, additional, ISHIBIKI, Kyuya, additional, AIKAWA, Naoki, additional, IKEMOTO, Hideo, additional, WATANABE, Kazuyoshi, additional, HATANO, Michinobu, additional, SEKI, Masato, additional, YOSHIDA, Sho, additional, WONG, Pakming, additional, FUJIMORI, Ippei, additional, KOBAYASHI, Yoshio, additional, OHKUBO, Takao, additional, MARUTA, Ichiro, additional, YURA, Jiro, additional, Ito, Minoru, additional, MISIMA, Akira, additional, TAKEUCHI, Toshihiko, additional, KATO, Masahito, additional, YAMAMOTO, Toshiyuki, additional, KAWAMURA, Hidekazu, additional, SUZUKI, Kanzo, additional, TANIMURA, Hiroshi, additional, MORI, Keiichiro, additional, SAKAI, Katsuji, additional, UEDA, Takami, additional, FUJIMOTO, Mikio, additional, ORITA, Kunzo, additional, HAMASAKI, Keisuke, additional, FUJII, Chiiho, additional, YOKOYAMA, Takashi, additional, MIYOSHI, Nobukazu, additional, KURIMURA, Osamu, additional, IHARA, Akihiro, additional, NAKAYAMA, Fumio, additional, KAYASHIMA, Koji, additional, IWASAKI, Kazunori, additional, SAWAE, Yoshiro, additional, SHIMURA, Hidehiko, additional, TAMAMOTO, Hiroshi, additional, HARA, Kohei, additional, SAITYO, Atsushi, additional, SHIGENO, Yoshiteru, additional, YAMAGUCHI, Keizo, additional, KOHNO, Shigeru, additional, IZUMIKAWA, Kinichi, additional, WATANABE, Koichi, additional, MIYAUCHI, Yoshimasa, additional, ITOGA, Takashi, additional, HOSOKAWA, Takafumi, additional, and HORI, Takashi, additional
- Published
- 1985
- Full Text
- View/download PDF
158. High incidence of postoperative metabolic alkalosis in surgical patients.
- Author
-
OKUSAWA, SEIJIRO, primary, AIKAWA, NAOKI, additional, and ABE, OSAHIKO, additional
- Published
- 1985
- Full Text
- View/download PDF
159. Extrapulmonary factors influencing the ratio of arterial oxygen tension to inspired oxygen concentration in burn patients
- Author
-
JEEVENDRA MARTYN, J. A., primary, AIKAWA, NAOKI, additional, WILSON, ROGER S., additional, SZYFELBEIN, STANISLAW K., additional, and BURKE, JOHN F., additional
- Published
- 1979
- Full Text
- View/download PDF
160. Modified abbreviated burn severity index as a predictor of in-hospital mortality in patients with inhalation injury: development and validation using independent cohorts.
- Author
-
Yamamoto, Ryo, Shibusawa, Takayuki, Aikawa, Naoki, and Sasaki, Junichi
- Subjects
- *
HOSPITAL mortality , *INHALATION injuries , *MISSING data (Statistics) , *ARTIFICIAL respiration , *LOGISTIC regression analysis - Abstract
Purpose: The ability to accurately evaluate the severity of inhalation injury can help to optimize patient care. However, there is no accepted severity grading system, especially for inhalation injury. Methods: We screened a multicenter burn registry and included adult patients who required oxygen treatment or mechanical ventilation. After the patient data were divided into development and validation cohorts, missing values were replaced with multiple imputation. Twelve potential predictors were analyzed using multivariate logistic regression to identify prognostic variables for in-hospital mortality and scores were assigned to each predictor based on odds ratios to develop the Modified Abbreviated Burn Severity Index, mABSI. The mABSI was validated using c-statistics and calibration curves. Results: We randomly assigned 1377 and 919 patients to the development and validation cohorts, respectively. Age, self-inflicted injury, cutaneous burn area, and mechanical ventilation requirement were identified as independent predictors, and the mABSI (1–17 scale) was, thus, developed. The mABSI has a high discriminatory power (c-statistic = 0.94; 95% CI 0.92–0.97), and both estimated and observed in-hospital mortalities increased from 1% at score ≤ 5 to almost 100% at score ≥ 14 with linear calibration plots. Conclusions: We developed and validated the mABSI which accurately predicts in-hospital mortality. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
161. commentaries Medical licensure examination for the visually impaired in Japan.
- Author
-
Aikawa, Naoki, Kimura, Shingo, and Namba, Yoshio
- Subjects
- *
PHYSICIANS , *PEOPLE with visual disabilities , *EXAMINATIONS , *MEDICAL education ,STUDY & teaching of medicine - Abstract
Reports that on August 7, 2003, the Ministry of Health, Labor and Welfare (MHLW) of Japan announced that a visually impaired individual had been granted a Medical Practitioner's License for the first time in the history of the Japanese medical licensure system. Need to pass the National Examination for Medical Practitioners; Use of diverse pictorial material in the test that must be visually analyzed.
- Published
- 2004
- Full Text
- View/download PDF
162. The impact of body temperature abnormalities on the disease severity and outcome in patients with severe sepsis: an analysis from a multicenter, prospective survey of severe sepsis.
- Author
-
Kushimoto, Shigeki, Gando, Satoshi, Saitoh, Daizoh, Mayumi, Toshihiko, Ogura, Hiroshi, Fujishima, Seitaro, Araki, Tsunetoshi, Ikeda, Hiroto, Kotani, Joji, Miki, Yasuo, Shiraishi, Shin-Ichiro, Suzuki, Koichiro, Suzuki, Yasushi, Takeyama, Naoshi, Takuma, Kiyotsugu, Tsuruta, Ryosuke, Yamaguchi, Yoshihiro, Yamashita, Norio, Aikawa, Naoki, and JAAM Sepsis Registry (JAAMSR) Study Group
- Subjects
APACHE (Disease classification system) ,BODY temperature regulation ,CLINICAL trials ,FEVER ,HYPOTHERMIA ,LONGITUDINAL method ,NONPARAMETRIC statistics ,PROGNOSIS ,SEPSIS ,HOSPITAL mortality ,DISEASE complications ,MORTALITY - Abstract
Introduction: Abnormal body temperatures (Tb) are frequently seen in patients with severe sepsis. However, the relationship between Tb abnormalities and the severity of disease is not clear. This study investigated the impact of Tb on disease severity and outcomes in patients with severe sepsis.Methods: We enrolled 624 patients with severe sepsis and grouped them into 6 categories according to their Tb at the time of enrollment. The temperature categories (≤ 35.5 °C, 35.6-36.5 °C, 36.6-37.5 °C, 37.6-38.5 °C, 38.6-39.5 °C, ≥ 39.6 °C) were based on the temperature data of the Acute Physiology and Chronic Health Evaluation II (APACHE II) scoring. We compared patient characteristics, physiological data, and mortality between groups.Results: Patients with Tb of ≤ 36.5 °C had significantly worse sequential organ failure assessment (SOFA) scores when compared with patients with Tb >37.5 °C on the day of enrollment. Scores for APACHE II were also higher in patients with Tb ≤ 35.5 °C when compared with patients with Tb >36.5 °C. The 28-day and hospital mortality was significantly higher in patients with Tb ≤ 36.5 °C. The difference in mortality rate was especially noticeable when patients with Tb ≤ 35.5 °C were compared with patients who had Tb of >36.5 °C. Although mortality did not relate to Tb ranges of ≥ 37.6 °C as compared to reference range of 36.6-37.5 °C, relative risk for 28-day mortality was significantly greater in patients with 35.6-36.5 °C and ≤ 35.5 °C (odds ratio; 2.032, 3.096, respectively). When patients were divided into groups based on the presence (≤ 36.5 °C, n = 160) or absence (>36.5 °C, n = 464) of hypothermia, disseminated intravascular coagulation (DIC) as well as SOFA and APACHE II scores were significantly higher in patients with hypothermia. Patients with hypothermia had significantly higher 28-day and hospital mortality rates than those without hypothermia (38.1% vs. 17.9% and 49.4% vs. 22.6%, respectively). The presence of hypothermia was an independent predictor of 28-day mortality, and the differences between patients with and without hypothermia were observed irrespective of the presence of septic shock.Conclusions: In patients with severe sepsis, hypothermia (Tb ≤ 36.5 °C) was associated with increased mortality and organ failure, irrespective of the presence of septic shock.Trial Registration: UMIN-CTR ID UMIN000008195. [ABSTRACT FROM AUTHOR]- Published
- 2013
- Full Text
- View/download PDF
163. CT scans essential after posttraumatic loss of consciousness
- Author
-
Inamasu, Joji, Hori, Shingo, Aoki, Katsunori, Suga, Sadao, Kawase, Takeshi, and Aikawa, Naoki
- Abstract
The frequency of “talk and deteriorate” in the emergency department (ED), subsequent deterioration of patients with seemingly “mild” head injury at the time of presentation, is summarized. Among the 1,073 patients with minor head injury treated in the last 5 years, five patients (0.5%) deteriorated in the ED. All of the five patients had experienced transient loss of consciousness (LOC) before presentation. Deterioration had occurred during treatment of trivial associated injuries in four-fifths of the cases. Computed tomography (CT) scans revealed four acute epidural hematomas and one cerebellar contusion. Retrospectively, immediate brain CT shortly after their arrival may have revealed the presence of traumatic intracranial hematomas before deterioration. Although routine use of CT scans in patients with mild head injury has been controversial, the authors conclude that CT scans shouldbe taken if patients have experienced transient LOC to prevent or reduce the occurrence of deteriolation in ED. (Am J Emerg Med 2000;18:810-811. Copyright © 2000 by W.B. Saunders Company)
- Published
- 2000
- Full Text
- View/download PDF
164. Relationship between neutrophil elastase and acute lung injury in humans
- Author
-
Tamakuma, Shouetsu, Ogawa, Michio, Aikawa, Naoki, Kubota, Tatsuya, Hirasawa, Hiroyuki, Ishizaka, Akitoshi, Taenaka, Nobuyuki, Hamada, Chikuma, Matsuoka, Shozo, and Abiru, Taira
- Subjects
- *
LUNG injuries , *PATIENTS , *CLINICAL trials , *LEUCOCYTE elastase - Abstract
We conducted clinical trials in patients with acute lung injury (ALI) associated with systemic inflammatory response syndrome using a selective neutrophil elastase inhibitor, sivelestat sodium hydrate (Sivelestat), to investigate the involvement of neutrophil elastase in ALI. In the phase III double-blind study (Study 1) in 230 patients, the efficacy of Sivelestat was evaluated with the pulmonary function improvement (PFI) rating as the primary endpoint, and the weaning rate from mechanical ventilator, the discharge rate from intensive care unit (ICU), and the survival rate as secondary endpoints. Afterwards, an unblinded study (Study 2) in 20 patients was conducted using procedures for weaning from mechanical ventilation to reevaluate its efficacy with ventilator-free days (VFD) value, the primary endpoint, and to compare with that of Study 1 subgroup, which met the selection criteria used in Study 2. Sivelestat increased PFI rating, reduced duration of mechanical ventilation, and shortened stay in ICU in Study 1, although there was no significant efficacy on the survival rate. VFD value in Study 2 was comparable to that in the optimal-dose group of Study 1 subgroup, and increase in VFD value correlated with PFI rating and increase in ICU free days. It was concluded that neutrophil elastase may be involved in the pathogenesis of ALI in humans. [Copyright &y& Elsevier]
- Published
- 2004
- Full Text
- View/download PDF
165. Correlation between pharmacokinetic/pharmacodynamic indices and clinical outcomes in Japanese patients with skin and soft tissue infections treated with daptomycin: analysis of a phase III study.
- Author
-
Takesue, Yoshio, Mikamo, Hiroshige, Kusachi, Shinya, Watanabe, Shinichi, Takahashi, Kenichi, Yoshinari, Tomoko, Ishii, Mikio, and Aikawa, Naoki
- Subjects
- *
SKIN infections , *PEPTIDE drugs , *SOFT tissue infections , *PHARMACOKINETICS , *PHARMACODYNAMICS , *STATISTICAL correlation , *HEALTH outcome assessment , *JAPANESE people , *PATIENTS , *DISEASES - Abstract
The relationships between pharmacokinetic (PK)/pharmacodynamic (PD) indices and outcomes were investigated in patients with skin and soft tissue infection (SSTI) who received daptomycin at 4 mg/kg/day. Efficacy was evaluated in 55 patients from whom Staphylococcus aureus was isolated, with success rates of 94.5% and 69.1% for clinical and microbiological responses, respectively. The odds ratio for the relationship between the area under the day 1 concentration–time curve (AUC 0–24 h ) to the MIC and the probability of clinical success was 1.03 (95% confidence interval [CI] 0.73–1.45), and that for the relationship for probability of microbiological success was 0.94 (95% CI 0.81–1.09). In 82 patients in the safety analysis, only 1 met the creatine phosphokinase (CPK) elevation criteria, and this patient's minimum concentration (C min ) of plasma daptomycin was 5.37 μg/mL. No significant relationship was found between peak CPK and C min (Pearson's correlation coefficient −0.0452). In conclusion, no clear correlation between PK/PD indices and the probability of efficacy or safety events was demonstrated when daptomycin was administered in SSTI patients using the clinically recommended dosage of 4 mg/kg/day. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
166. Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trial.
- Author
-
Opal, Steven M, Laterre, Pierre-Francois, Francois, Bruno, LaRosa, Steven P, Angus, Derek C, Mira, Jean-Paul, Wittebole, Xavier, Dugernier, Thierry, Perrotin, Dominique, Tidswell, Mark, Jauregui, Luis, Krell, Kenneth, Pachl, Jan, Takahashi, Takeshi, Peckelsen, Claus, Cordasco, Edward, Chang, Chia-Sheng, Oeyen, Sandra, Aikawa, Naoki, and Maruyama, Tatsuya
- Abstract
Importance: Eritoran is a synthetic lipid A antagonist that blocks lipopolysaccharide (LPS) from binding at the cell surface MD2-TLR4 receptor. LPS is a major component of the outer membrane of gram-negative bacteria and is a potent activator of the acute inflammatory response.Objective: To determine if eritoran, a TLR4 antagonist, would significantly reduce sepsis-induced mortality.Design, Setting, and Participants: We performed a randomized, double-blind, placebo-controlled, multinational phase 3 trial in 197 intensive care units. Patients were enrolled from June 2006 to September 2010 and final follow-up was completed in September 2011.Interventions: Patients with severe sepsis (n = 1961) were randomized and treated within 12 hours of onset of first organ dysfunction in a 2:1 ratio with a 6-day course of either eritoran tetrasodium (105 mg total) or placebo, with n = 1304 and n = 657 patients, respectively.Main Outcome Measures: The primary end point was 28-day all-cause mortality. The secondary end points were all-cause mortality at 3, 6, and 12 months after beginning treatment.Results: Baseline characteristics of the 2 study groups were similar. In the modified intent-to-treat analysis (randomized patients who received at least 1 dose) there was no significant difference in the primary end point of 28-day all-cause mortality with 28.1% (366/1304) in the eritoran group vs 26.9% (177/657) in the placebo group (P = .59; hazard ratio, 1.05; 95% CI, 0.88-1.26; difference in mortality rate, -1.1; 95% CI, -5.3 to 3.1) or in the key secondary end point of 1-year all-cause mortality with 44.1% (290/657) in the eritoran group vs 43.3% (565/1304) in the placebo group, Kaplan-Meier analysis of time to death by 1 year, P = .79 (hazard ratio, 0.98; 0.85-1.13). No significant differences were observed in any of the prespecified subgroups. Adverse events, including secondary infection rates, did not differ between study groups.Conclusions and Relevance: Among patients with severe sepsis, the use of eritoran, compared with placebo, did not result in reduced 28-day mortality.Trial Registration: clinicaltrials.gov Identifier: NCT00334828. [ABSTRACT FROM AUTHOR]- Published
- 2013
- Full Text
- View/download PDF
167. Clinical efficacy and safety of intravenous itraconazole in the management of invasive candidiasis in patients of surgery and critical care.
- Author
-
Takesue, Yoshio, Oda, Shigeto, Fujishima, Seitaro, Mikamo, Hiroshige, and Aikawa, Naoki
- Subjects
- *
CANDIDIASIS treatment , *INTRAVENOUS therapy , *CRITICAL care medicine , *SURGERY - Abstract
Although itraconazole exhibits potent activity against Candida species, there have been few studies examining the use of intravenous itraconazole in the treatment of invasive candidiasis. A nationwide multicenter clinical study was conducted to evaluate the efficacy and safety of intravenous itraconazole in the management of invasive candidiasis, including non- albicans Candida species, in non-neutropenic patients undergoing surgery and critical care. Between September 2007 and August 2009, patients with proven and presumed candidiasis were enrolled at 22 participating institutions. Patients with presumed candidiasis had a deep-body temperature of 37.8°C or higher and were positive for serum β- d-glucan or two or more colonization sites of Candida species. The main exclusion criterion was severe renal impairment (creatinine clearance <30 ml/min). The primary efficacy analysis was based on clinical and microbiological responses 5-10 days after the end of treatment, assessed by an independent data review committee. Of the 60 patients enrolled, 49 were included in the modified intention-to-treat population; 31 patients received a definitive diagnosis and 18 patients a presumed diagnosis. Intravenous itraconazole was used as first-line therapy to treat 39 patients and as second-line therapy for 10 patients. The isolated species included Candida albicans (25 strains with definitive diagnosis and 17 with presumed diagnosis) and non- albicans species (16 and 10, respectively). Treatment was successful in 61.5% patients (65.5% in first-line and 50.0% in second-line therapy); 60% of proven invasive candidiasis (IC) patients were judged as successful compared with 63.2% of presumed candidiasis patients. Eradication rate was 63.6% for C. albicans and 71.4% for C. glabrata. Adverse effects occurred in 9 of 60 patients (15.0%), commonly impaired liver function. The clinical efficacy and safety of intravenous itraconazole were suggested in the management of proven and presumed candidiasis including C. glabrata in non-neutropenic patients. The status of intravenous itraconazole in the Japanese guideline warrants reconsideration. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
168. Antimicrobial-susceptible patterns of Staphylococcus aureus isolated from surgical infections: a new approach.
- Author
-
Suzuki, Masaru, Miyaki, Masaru, Sekine, Kazuhiko, Kurihara, Tomohiro, Abe, Shinya, Aikawa, Naoki, and Shinagawa, Nagao
- Subjects
- *
STAPHYLOCOCCUS aureus , *STAPHYLOCOCCAL diseases , *SURGICAL complications , *ANTI-infective agents , *DRUG resistance in microorganisms - Abstract
Our goal was to analyze minimum inhibitory concentration (MIC) data for Staphylococcus aureus isolated from surgical infections (SIs) and to look for correlations among the clinically available antimicrobials that were tested. Clinical isolates from SIs were collected by a multicenter surveillance group involving 34 institutions in Japan. During the period April 1998 to March 2007, 312 strains of S. aureus [71 methicillin susceptible (MSSA) and 241 methicillin resistant (MRSA)] were consecutively obtained from these institutions. MIC data for 18 clinically available antimicrobial agents [ABPC, CEZ, CTM, CMX, CPR, FMOX, CFPM, CZOP, IPM, MEMP, GM, ABK, MINO, CLDM, FOM, LVFX, VCM, and TEIC (abbreviations defined in Tables 2 and 3)] against these isolates was analyzed using a principal component analysis (PCA). PCA revealed that four principal components explained 71.1% of the total variance. The first component consisted of major contributions from MEPM and IPM. The second component consisted of major contributions from MINO. These two-first axes, which were strong and explained 54.2% of the total variance, were able to classify the clinical isolates into four clusters. Furthermore, the proportion of the four clusters provided the characteristics of the S. aureus that were clinically isolated at each institute. PCA is a clinically applicable method for analyzing MIC patterns. Such analyses might contribute to the establishment of a practical classification of antimicrobial agents and to the identification of the characteristic antimicrobial resistance patterns at each institute. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
169. A comparison of Ringer's lactate and acetate solutions and resuscitative effects on splanchnic dysoxia in patients with extensive burns
- Author
-
Aoki, Katsunori, Yoshino, Atsuto, Yoh, Kikuo, Sekine, Kazuhiko, Yamazaki, Motoyasu, and Aikawa, Naoki
- Subjects
- *
LACTATES , *ACETATES , *SOLUTION (Chemistry) , *BURNS & scalds , *GASTRIC mucosa , *PATIENTS , *KETONES , *ANTITHROMBINS , *TREATMENT for burns & scalds , *ACTIVE oxygen in the body , *ANALYSIS of variance , *BIOMARKERS , *BLOOD testing , *BLOOD plasma substitutes , *COMPARATIVE studies , *COMPUTER software , *HYDROGEN-ion concentration , *REGRESSION analysis , *T-test (Statistics) , *TONOMETRY , *DATA analysis , *EQUIPMENT & supplies - Abstract
We compared the effects of Ringer's lactate (RL) and acetate (RA) solutions on parameters of splanchnic dysoxia such as PgCO2 (PCO2 of gastric mucosa) and pHi (pH of gastric mucosa) using a gastric tonometer, in addition to blood markers such as the serum arterial level of lactate, base excess, ketone body ratio, and antithrombin during the first 72h of the resuscitation period in patients with burns covering 30% or more of their body surface. A prospective study was conducted in the university tertiary referral centers. There were no significant differences in the average age, TBSA (total burn surface area), and resuscitative fluid volume during the first and second 24h between the two groups. In the RA group, PCO2 gap values calculated employing the formula: PgCO2 −PaCO2 (arterial PCO2), and pH gap calculated by: pHa (arterial pH)−pHi, improved to the normal ranges at 24h postburn, which was significantly faster than in the RL group. On the other hand, there were no significant differences in blood parameters between the two groups over the course. These results suggest that fluid resuscitation with RA may more rapidly ameliorate splanchnic dysoxia, as evidenced by gastric tonometry, compared to that with RL. [Copyright &y& Elsevier]
- Published
- 2010
- Full Text
- View/download PDF
170. Production and Activation of Matrix Metalloproteinase 7 (Matrilysin 1) in the Lungs of Patients With Idiopathic Pulmonary Fibrosis.
- Author
-
Fujishima, Seitaro, Shiomi, Takayuki, Yamashita, Shuji, Yogo, Yurika, Nakano, Yasushi, Inoue, Takashi, Nakamura, Morio, Tasaka, Sadatomo, Hasegawa, Naoki, Aikawa, Naoki, Ishizaka, Akitoshi, and Okada, Yasunori
- Subjects
- *
METALLOPROTEINASES , *PULMONARY fibrosis , *INFLAMMATION , *FIBROBLASTS , *EXTRACELLULAR matrix , *IMMUNOHISTOCHEMISTRY , *PNEUMONIA , *BRONCHOALVEOLAR lavage - Abstract
Context.--Idiopathic pulmonary fibrosis (IPF) is characterized by diffuse interstitial inflammation and fibroblast proliferation with accelerated remodeling of extracellular matrix, which result in irreversible destruction of the lung's architecture. Objective.--To elucidate the production levels, tissue localization, and activation of matrix metalloproteinase 7 (MMP-7) in the lungs of patients with IPF. Design.--Bronchoalveolar lavage analysis was performed in 17 IPF patients and 6 healthy volunteers. Levels of MMP-7 in blood were assayed in 23 IPF patients and 20 controls. Histologic and immunohistochemical analyses were performed on paraffin sections of the lung tissues from patients with IPF, interstitial pneumonia associated with rheumatoid arthritis, or nonspecific interstitial pneumonia. Results.--The proMMP-7 levels in bronchoalveolar lavage fluids from IPF patients were significantly higher than those from healthy controls, although there was no difference in the serum levels between the 2 groups. By immunohistochemistry, proMMP-7 was localized mainly to the hyperplastic alveolar and metaplastic bronchiolar epithelial cells in the lung tissues from IPF patients. Active MMP-7 was immunolocalized on alveolar macrophages and hyperplastic epithelial cells, which were also immunostained with antibody against CD151, a molecule associated with activation of proMMP-7. Immunoblot analysis indicated the overproduction of proMMP-7 together with a small amount of active MMP-7 in bronchoalveolar lavage fluids from IPF patients. The MMP-7 activity was detected in a cross-linked carboxymethylated transferrin film assay. Conclusions.--proMMP-7 is excessively produced by hyperplastic alveolar and metaplastic bronchiolar epithelial cells and activated locally in the lungs of IPF patients, suggesting that MMP-7 may contribute to the pathology of IPF. [ABSTRACT FROM AUTHOR]
- Published
- 2010
171. Neutrophil elastase and systemic inflammatory response syndrome in the initiation and development of acute lung injury among critically ill patients
- Author
-
Fujishima, Seitaro, Morisaki, Hiroshi, Ishizaka, Akitoshi, Kotake, Yoshifumi, Miyaki, Masaru, Yoh, Kikuo, Sekine, Kazuhiko, Sasaki, Junichi, Tasaka, Sadatomo, Hasegawa, Naoki, Kawai, Yohko, Takeda, Junzo, and Aikawa, Naoki
- Subjects
- *
LUNG diseases , *CYTOKINES , *NEUTROPHILS , *RESPIRATORY distress syndrome - Abstract
Abstract: Critically ill patients are commonly associated with systemic inflammatory response syndrome (SIRS) and are at a greater risk of developing acute lung injury (ALI) and acute respiratory distress syndrome (ARDS). Under these conditions, large amounts of various cytokines are produced, which either directly or indirectly induce tissue injury and finally organ dysfunctions, through the activation of neutrophils and as a result of release of cytotoxic molecules, especially neutrophil elastase (NE). In the present study, we determined plasma neutrophil elastase–alpha-1 antitrypsin complex (NE–AT) and elastase digests of cross-linked fibrin (e-XDP) in critically ill patients to elucidate the significance of NE in the initiation and progression of ALI and ARDS in the presence or absence of SIRS. We found significantly increased levels of plasma NE–AT in the patients with ARDS, especially when the definition of SIRS was met. Among ALI/ARDS groups, plasma NE–AT, but not e-XDP, correlated significantly with the decrease in PaO2/FIO2 ratio and the duration of ALI/ARDS. Furthermore, NE–AT, but not e-XDP, significantly increased in subgroups whose PaO2/FIO2 ratio decreased by more than 20%. Such correlations and differences between the subgroups were not observed in the non-ALI patients. From these results, we speculate that NE–AT, but not e-XDP, may be predictive of progressive lung injury in the early stage of ALI and ARDS. [Copyright &y& Elsevier]
- Published
- 2008
- Full Text
- View/download PDF
172. Blatchford scoring system is a useful scoring system for detecting patients with upper gastrointestinal bleeding who do not need endoscopic intervention.
- Author
-
Masaoka, Tatsuhiro, Suzuki, Hidekazu, Hori, Shingo, Aikawa, Naoki, and Hibi, Toshifumi
- Subjects
- *
GASTROINTESTINAL hemorrhage , *GASTRIC diseases , *EMERGENCY medical services , *BLOOD transfusion , *ENDOSCOPY , *HEALTH risk assessment - Abstract
Background and Aim: Several scoring systems have been devised to identify patients with upper gastrointestinal (UGI) bleeding who are at a high risk of adverse outcomes. We retrospectively evaluated the accuracy of the Blatchford scoring system for assessing the need for clinical intervention in cases of UGI bleeding admitted to the emergency department (ED). Methods: This was a retrospective study conducted on patients who underwent emergency GI endoscopy at the ED of our hospital. Those who needed blood transfusion, operative or endoscopic interventions to control the hemorrhage were classified into the ‘high risk’ group. Results: Of the 93 enrolled patients, 70 (75.3%) were classified into the high risk group. The Blatchford score was significantly higher in the high risk group than in the low risk group. When a cut-off value of 2 was used, the sensitivity and specificity of the Blatchford scoring system were determined to be 100% and 13%, respectively. Thus, the Blatchford scoring system was deemed to be useful for distinguishing between the high risk group and the low risk group of patients with GI hemorrhage admitted to the ED. Conclusion: The Blatchford scoring system is accurate for identifying definitively low-risk patients of GI hemorrhage, even prior to the performance of emergency UGI endoscopy at the ED. [ABSTRACT FROM AUTHOR]
- Published
- 2007
- Full Text
- View/download PDF
173. Efficacy of Micafungin Sodium on Fungal Infection in Critical Care.
- Author
-
Tateishi, Yoshihisa, Hirasawa, Hiroyuki, Oda, Shigeto, Nakanishi, Kazuya, Kitamura, Shinya, and Aikawa, Naoki
- Subjects
- *
ANTIFUNGAL agents , *MYCOSES , *CRITICALLY ill , *CANDIDA albicans - Abstract
The clinical effects and tolerability of micafungin sodium in daily practice for the treatment of fungal infection in critically ill patients were evaluated in an open-labeled, non-comparative, observational study. All patients admitted to intensive care units (ICUs) of 3 hospitals in Chiba prefecture between June 2003 and March 2005, who were treated with micafungin because of known or suspected fungal infection, were included in the study. A total of 34 patients received micafungin and 29 cases of them were subjected to analysis. Fungal infections were classified as "proven" in 3 patients (10.3%) and "possible" in 26 (89.7%). Candida was detected in 16 patients, most of them were Candida albicans and 4 cases were non-albicans Candida. Clinical effects of micafungin were "cured" and "improved" in 20 patients (77%), "failure" in 6 (23%), and "undetermined" in 3 cases. Adverse events were reported in 10 patients, but there was no significant event. In conclusion, micafungin was effective in 77% of proven or suspected fungal infections in critically ill patients admitted to the ICU. The drug was well tolerated and discontinuation of its treatment due to adverse events was not experienced during the study period. [ABSTRACT FROM AUTHOR]
- Published
- 2006
- Full Text
- View/download PDF
174. Prior burn insult induces lethal acute lung injury in endotoxemic mice: effects of cytokine inhibition.
- Author
-
Sasaki, Junichi, Fujishima, Seitaro, Iwamura, Hiroyuki, Wakitani, Korekiyo, Aiso, Sadakazu, and Aikawa, Naoki
- Subjects
- *
SEPSIS , *BURNS & scalds , *SEPTIC shock - Abstract
Many patients who experience surgical stress, including burn injury, become susceptible to severe sepsis and septic organ dysfunction, which remains the primary contributor to morbidity and mortality in burn patients. In the present study, we developed a murine model of burn-primed sublethal endotoxemia by producing a 15% BSA full-thickness burn on the dorsum of BALB/c mice under ether anesthesia and administering 10 mg/kg of LPS intravenously on day 11 to model endotoxemia. The prior burn injury in this model induced two-peaked production of cytokines, TNF-α, and macrophage inflammatory protein-2 at 2 and 12 h after LPS administration, and it was associated with increased mortality. We also assessed the effect of pharmacological modulation with cytokine synthesis inhibitors prednisolone and JTE-607 and found that pretreatment with them attenuated later cytokine production and decreased mortality after LPS administration. We speculate that the prior burn injury primed the mice for the secondary insult via cytokine production. These results also suggested that an anticytokine strategy might serve as a novel prophylactic therapy for septic organ dysfunction in burn-primed patients. [ABSTRACT FROM AUTHOR]
- Published
- 2003
- Full Text
- View/download PDF
175. Correlation between QT dispersion and burn severity.
- Author
-
Suzuki M, Aoki K, Sekine K, Aikawa N, Suzuki, Masaru, Aoki, Katsunori, Sekine, Kazuhiko, and Aikawa, Naoki
- Abstract
QT dispersion, defined as the maximal-minus-minimal QT interval on a 12-lead electrocardiogram, has emerged as a non-invasive measurement for quantifying the spatial inhomogeneity of ventricular repolarization under various conditions, including acute stress. Because burn injuries elicit acute stress reactions, it was hypothesized that QT dispersion increases with the severity of the burn injury. To test the hypothesis, 13 burned patients (age range of 22-76 years, nine males, ranging from 4.0 to 75.0% of total body surface area burned) in whom a measurable 12-lead electrocardiogram had been obtained within 4h after arrival at the emergency department were identified retrospectively, and their QTc intervals, i.e. QT intervals corrected for heart rate by the standard Bazett formula, were measured. QTc dispersion (QTcd) was then calculated, and correlations were assessed with burn severity (burn index, BI; prognostic burn index, PBI). Of the 13 patients, nine patients had a prolonged QTcd (>40 ms), and linear correlation analyses showed significant positive correlations between QTcd and both BI and PBI (r=0.61 and 0.62, respectively). In conclusion, QT dispersion was greater in the burned patients, and although the pathophysiology was unclear from the present study, the findings suggested that acute stress contributed to the spatial inhomogeneity of ventricular repolarization. [ABSTRACT FROM AUTHOR]
- Published
- 2002
- Full Text
- View/download PDF
176. Cardiopulmonary arrest induced by anaphylactoid reaction with contrast media
- Author
-
Nakamura, Iwao, Hori, Shingo, Funabiki, Tomohiro, Sekine, Kazuhiko, Kimura, Hiroyuki, Fujishima, Seitaro, Aoki, Katsunori, Kuribayashi, Sachio, and Aikawa, Naoki
- Subjects
- *
ANAPHYLAXIS , *CARDIAC arrest , *CONTRAST media , *CARDIOPULMONARY resuscitation , *EMERGENCY medicine - Abstract
Anaphylactoid reactions to iodinated contrast media can cause life-threatening events and even death. A 44-year-old woman presented with cardiopulmonary arrest (CPA) immediately following the administration of nonionic iodinated contrast media for an intravenous pyelography. Her cardiac rhythm during CPA was asystole. She was successfully resuscitated by the radiologists supported by paged emergency physicians using the prompt intravenous administration of 1 mg of epinephrine. Neither laryngeal edema nor bronchial spasm was observed during the course of treatment, and she was discharged on the 4th day without any complications. The patient did not have a history of allergy, but had experienced a myocardial infarction and aortitis. She had undergone 11 angiographies and had been taking a β-adrenergic receptor antagonist. Planned emergency medical backup is advisable to ensure resuscitation in the event of an anaphylactoid reaction to the use of contrast media in-hospital settings. [Copyright &y& Elsevier]
- Published
- 2002
- Full Text
- View/download PDF
177. Acute subdural hematoma caused by ruptured cerebral aneurysms: diagnostic and therapeutic pitfalls
- Author
-
Inamasu, Joji, Saito, Ryoichi, Nakamura, Yoshiki, Ichikizaki, Kiyoshi, Suga, Sadao, Kawase, Takeshi, Hori, Shingo, and Aikawa, Naoki
- Subjects
- *
SUBDURAL hematoma , *INTRACRANIAL aneurysms , *SUBARACHNOID hemorrhage - Abstract
On rare occasions, rupture of a cerebral aneurysm causes acute subdural hematoma (SDH) in addition to subarachnoid hemorrhage (SAH). The frequency of SDH resulting from aneurysmal rupture is summarized, and its clinical and radiological characteristics, as well as potential pitfalls in the diagnosis and the management of this life-threatening condition are described. Among 641 patients with nontraumatic SAH treated between 1992 and 2000, 12 patients (1.9%) presented with SDH due to aneurysmal rupture. The SAH grade on admission was grade II in one patient, grade IV in three patients, and grade V in eight patients. Four underwent both hematoma evacuation and clipping of the aneurysm, four underwent hematoma evacuation alone, and the other four patients were treated conservatively. The outcome was good recovery in two patients, severe disability in one patient, and death in nine patients. Patients with a good outcome had a better SAH grade on admission, smaller midline shift, and smaller SDH volume on the initial CT scan, and they had been treated by both SDH evacuation and clipping of the aneurysm. Emergency one-stage operations may be beneficial for aneurysmal SDH patients who are in good SAH grade, or those who are in poor SAH grade but show some neurological recovery after resuscitation. It should also be mentioned that there are cases of aneurysmal SDH without recognizable SAH on the CT scans, and that a case of aneurysmal SDH may present as a case of ‘head trauma’ after an accident, because of the disturbance of consciousness resulting from aneurysmal rupture. [Copyright &y& Elsevier]
- Published
- 2002
- Full Text
- View/download PDF
178. Diagnostic Implications of Elevated Levels of Smooth-Muscle Myosin Heavy-Chain Protein in Acute Aortic Dissection.
- Author
-
Suzuki, Toru, Katoh, Hirohisa, Tsuchio, Yasuhiro, Hasegawa, Akira, Kurabayashi, Masahiko, Ohira, Atsushi, Hiramori, Katsuhiko, Sakomura, Yasunari, Kasanuki, Hiroshi, Hori, Shingo, Aikawa, Naoki, Abe, Satoshi, Tei, Chuwa, Nakagawa, Yoshihasa, Nobuyoshi, Masakiyo, Misu, Kazuhiko, Sumiyoshi, Tetsuya, and Nagai, Ryozo
- Subjects
- *
MUSCLE proteins , *AORTIC dissection , *MYOCARDIAL infarction - Abstract
Evaluates the sensitivity and specificity of a study on circulating smooth-muscle myosin heavy-chain protien as a bio-chemical diagnostic tool for aortic dissection. Participation of patients with acute aortic dissection, acute myocardial infraction and healthy volunteers; Increased levels of circulating smooth-muscle myosin heavy-chain protein in aortic patients; Assay sensitivity; Specificity of other particpants.
- Published
- 2000
- Full Text
- View/download PDF
179. Effects of thrombomodulin alfa on hemostatic parameters in disseminated intravascular coagulation: Post hoc analysis of a phase 3 randomized controlled trial.
- Author
-
Ito T, Maruyama I, Shimazaki S, Yamamoto Y, Aikawa N, Hirayama A, Honda G, and Saito H
- Abstract
Background: The efficacy and safety of thrombomodulin alfa (TM-α), a cofactor protein promoting thrombin-mediated protein C activation, have been examined in a phase 3 randomized, double-blinded, parallel-group trial in Japan. We have previously reported that TM-α is noninferior to heparin for the resolution of disseminated intravascular coagulation (DIC)., Objective: To investigate the basis for the efficacy of TM-α in the phase 3 clinical trial in Japan through post hoc analysis of coagulation and fibrinolysis parameters., Patients/methods: The 227 patients of the full analysis set population described in the original phase 3 trial in Japan were included in this analysis. Changes in parameters between before and after TM-α or heparin administration in each of the two patient groups, with underlying diseases of either hematologic malignancy or infection, were studied separately and results were compared between TM-α and heparin treatment groups in a post hoc manner., Results: TM-α administration did not prolong activated partial thromboplastin time but significantly decreased thrombin-antithrombin complex levels compared with heparin treatment. TM-α administration reduced consumption of endogenous anticoagulants such as antithrombin and protein C by DIC, compared with the heparin group. DIC scores were decreased in both TM-α and heparin groups during the 6-day treatment., Conclusion: TM-α can alleviate intravascular coagulation and consumption of anticoagulants without extending coagulation times. This may be associated with the relatively low risk of bleeding during TM-α treatment., (© 2020 The Authors. Research and Practice in Thrombosis and Haemostasis published by Wiley Periodicals LLC on behalf of International Society on Thrombosis and Haemostasis.)
- Published
- 2020
- Full Text
- View/download PDF
180. Complementary Role of Hypothermia Identification to the Quick Sequential Organ Failure Assessment Score in Predicting Patients With Sepsis at High Risk of Mortality: A Retrospective Analysis From a Multicenter, Observational Study.
- Author
-
Kushimoto S, Gando S, Ogura H, Umemura Y, Saitoh D, Mayumi T, Fujishima S, Abe T, Shiraishi A, Ikeda H, Kotani J, Miki Y, Shiraishi SI, Suzuki K, Suzuki Y, Takeyama N, Takuma K, Tsuruta R, Yamaguchi Y, Yamashita N, and Aikawa N
- Subjects
- Aged, Aged, 80 and over, Female, Humans, Intensive Care Units, Male, Middle Aged, Predictive Value of Tests, Prospective Studies, Retrospective Studies, Hospital Mortality, Hypothermia mortality, Organ Dysfunction Scores, Sepsis mortality
- Abstract
Background: Although the quick Sequential Organ Failure Assessment (qSOFA) has been recommended for identifying patients at higher risk of hospital death, it has only a 60% sensitivity for in-hospital mortality. On the other hand, hypothermia associates with increased mortality and organ failure in patients with sepsis. This study aimed to assess the predictive validity of qSOFA for identifying patients with sepsis at higher risk of multiple organ dysfunction or death and the complementary effect of hypothermia., Methods: Patients with severe sepsis admitted to intensive care units (ICUs) were retrospectively analyzed. The predictive validities of qSOFA (≥2, positive) and the complementary effect of hypothermia (body temperature ≤36.5°C) for the identification of death or multiorgan dysfunction were evaluated., Results: Of the 624 patients, 230 (36.9%) developed multiorgan dysfunction and 144 (23.1%) died within 28 days; 527 (84.5%) had a positive qSOFA. The 28-day mortality rates of patients with positive and negative qSOFA were 25.4% and 10.3%, respectively ( P = .001). The rate of positive qSOFA was higher in patients with multiorgan dysfunction (sensitivity, 0.896; specificity, 0.185) and among patients who died within 28 days (sensitivity, 0.931; specificity, 0.181); 10 (6.9%) of 144 deaths were not identified. In cases of positive qSOFA without hypothermia, positive qSOFA + hypothermia, or negative qSOFA with hypothermia, the predictive value for 28-day mortality improved (sensitivity, 0.979). Among the 144 patients who died, only 3 were not identified., Conclusion: A qSOFA score ≥2 may identify >90% of 28-day deaths among patients with severe sepsis; hypothermia may complement the predictive ability of qSOFA.
- Published
- 2020
- Full Text
- View/download PDF
181. Correlation of the Blood Test Results Obtained between Assays Using Microliter-scale Fingertip Blood Samples Collected with a Novel Blood Collection Device and Conventional Venous Blood Assays: a Secondary Publication in English.
- Author
-
Iwasawa H, Nishimura T, Nemoto S, Aikawa N, and Watanabe K
- Subjects
- Adult, Aged, Aspartate Aminotransferases blood, Blood Cell Count instrumentation, Blood Glucose metabolism, Blood Specimen Collection instrumentation, Cholesterol, HDL blood, Cholesterol, LDL blood, Female, Fingers blood supply, Glycated Hemoglobin metabolism, Healthy Volunteers, Hematocrit, Humans, Male, Middle Aged, Reference Values, Triglycerides blood, gamma-Glutamyltransferase blood, Blood Cell Count methods, Blood Cell Count standards, Blood Specimen Collection methods, Blood Specimen Collection standards
- Abstract
In this study, we investigated the correlations between biochemical and hematological test results obtained using microliter-scale fingertip blood samples collected with a newly developed blood collection device and those obtained using conventional venous blood. Eighty volunteer subjects were enrolled in this study. Blood samples were drawn from the fingertip of the ring finger by a single puncture, and 60-µL samples were promptly and accurately aspirated into a blood collection chip. Then the chip was tightly sealed in a chip container and was shaken to mix the contents without dispersion. For biochemical tests other than that for HbA1c, blood was collected without anticoagulant and centrifuged to obtain 15 µL of serum which was then diluted with 190 µL of physiological saline for the assay. For hematological tests and the test for HbA1c, the sample was assayed with blood collected using EDTA-2 K. Good correlations were obtained between the test results of the assay using fingertip blood and that using venous blood. The correlation coefficients were ≥0.97 for TG, T-CHO, HDL-C, LDL-C, GLU, ALT, γ-GTP, UA, BUN, and HbA1c and ≥0.95 for WBC, RBC, Hgb, and Hct. These results suggest that our microliter-scale blood testing system is comparable to assays using venous blood and may be useful as a rapid and simple test to determine basic clinical parameters that are close to the reference intervals.
- Published
- 2018
- Full Text
- View/download PDF
182. Assessment of mortality by qSOFA in patients with sepsis outside ICU: A post hoc subgroup analysis by the Japanese Association for Acute Medicine Sepsis Registry Study Group.
- Author
-
Umemura Y, Ogura H, Gando S, Kushimoto S, Saitoh D, Mayumi T, Fujishima S, Abe T, Ikeda H, Kotani J, Miki Y, Shiraishi SI, Shiraishi A, Suzuki K, Suzuki Y, Takeyama N, Takuma K, Tsuruta R, Yamaguchi Y, Yamashita N, and Aikawa N
- Subjects
- Aged, Aged, 80 and over, Female, Humans, Hypothermia etiology, Japan epidemiology, Male, Middle Aged, Predictive Value of Tests, Prognosis, Prospective Studies, ROC Curve, Retrospective Studies, Sepsis complications, Survivors statistics & numerical data, Hospital Mortality, Hypothermia mortality, Organ Dysfunction Scores, Registries statistics & numerical data, Sepsis mortality
- Abstract
Quick sequential organ failure assessment (qSOFA) was proposed in the new sepsis definition (Sepsis-3). Although qSOFA was created to identify patients with suspected infection and likely to have poor outcomes, the clinical utility of qSOFA to screen sepsis has not been fully evaluated. We investigated the number of patients diagnosed as having severe sepsis who could not be identified by the qSOFA criteria and what clinical signs could complement the qSOFA score. This retrospective analysis of a multicenter prospective registry included adult patients with severe sepsis diagnosed outside the intensive care unit (ICU) by conventional criteria proposed in 2003. We conducted receiver operating characteristic (ROC) analyses to assess the predictive value for in-hospital mortality and compared clinical characteristics between survivors and non-survivors with qSOFA score ≤ 1 point (qSOFA-negative). Among 387 eligible patients, 63 (16.3%) patients were categorized as qSOFA-negative, and 10 (15.9%) of these patients died. The area under the ROC curve for the qSOFA score was 0.615, which was superior to that for the systemic inflammatory response syndrome score (0.531, P = 0.019) but inferior to that for the SOFA score (0.702, P = 0.005). Multivariate logistic regression analysis showed that hypothermia might be associated with poor outcome independently of qSOFA criteria. Our findings suggested that qSOFA had a suboptimal level of predictive value outside the ICU and could not identify 16.3% of patients who were once actually diagnosed with sepsis. Hypothermia might be associated with an increased risk of death that cannot be identified by qSOFA., (Copyright © 2017 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2017
- Full Text
- View/download PDF
183. Early evaluation of severity in patients with severe sepsis: a comparison with "septic shock" - subgroup analysis of the Japanese Association for Acute Medicine Sepsis Registry (JAAM-SR).
- Author
-
Tarui T, Yamaguchi Y, Suzuki K, Tsuruta R, Ikeda H, Ogura H, Kushimoto S, Kotani J, Shiraishi SI, Suzuki Y, Takuma K, Takeyama N, Fujishima S, Mayumi T, Miki Y, Yamashita N, Aikawa N, and Gando S
- Abstract
Aim: The purpose of this subgroup analysis of a Japanese multicenter registry, the Japanese Association for Acute Medicine Sepsis Registry Advanced (JAAM-SR-Advanced), was to identify early outcome indicators for severe sepsis that are useful and more objective than "septic shock.", Methods: Among 624 patients with severe sepsis registered in JAAM-SR-Advanced, 554 with valid serum lactate data were retrospectively studied. Hypotension before and after fluid resuscitation and the highest lactate values over the initial 24 h were compared for their ability to predict in-hospital mortality., Results: Of the study group, 155 (28.0%) patients were non-survivors and had significantly lower systolic blood pressures and higher lactate peaks. The mortality of 364 patients with initial hypotension was higher than those patients without it (32.7% versus 19.1%, P < 0.01). Patients with the worst lactate values ≥4 mmol/L had much higher mortality than other patients ( P < 0.001). In an attempt to predict outcomes, we combined initial hypotension and the worst lactate values. The patient group with initial hypotension and the worst lactate values ≥4 mmol/L (183 patients, 33.0%) had a significantly higher mortality rate of 48.6% than the other groups ( P < 0.01)., Conclusion: The novel combined criterion of initial hypotension and the worst lactate values ≥4 mmol/L within the initial 24 h is potentially useful as a single outcome predictor for severe sepsis.
- Published
- 2017
- Full Text
- View/download PDF
184. [Correlation of the Blood Test Results Obtained Between Assays Using Microliter-Scale Fingertip Blood Samples Collected with a Novel Blood Collection Device and Conventional Venous Blood Assays].
- Author
-
Iwasawa H, Nishimura T, Nemotc S, Aikawa N, and Watanabe K
- Subjects
- Anticoagulants, Fingers, Humans, Reference Values, Blood Specimen Collection methods
- Abstract
In this study, we investigated the correlations of values of biochemical and hematological tests obtained using microliter-scale fingertip blood samples collected with a newly developed blood collection device with those using conventional venous blood. Eighty volunteer subjects were enrolled in the study. Blood sam- ples were drawn from the fingertip of the ring finger by a single puncture and 60 μL of each sample was promptly and accurately aspirated into a blood collection chip. Then the chip was tightly sealed with chip container and was shaken to mix the contents without dispersing. For biochemical tests except of HbAlc, blood was collected without anticoagulant and centrifuged to obtain 15 μL of serum which was then diluted with 190 pL of physiological saline for the assay. For hematological tests and HbAlc, the sample was as- sayed with blood collected using EDTA-2K. As a result, a good correlation of the test values was obtained between the assay with fingertip blood and that with venous blood. The correlation coefficients were found to be 0.97 in TG, T-CHO, HDL-C, LDL-C, GLU, ALT, γ-GTP, UA, BUN and HbAlc and ≥ 0.95 for WBC, RBC, Hgb, and Hct. These results suggest that our microliter-scale blood testing can be comparable to the assay using venous blood and may be useful as a rapid and simple test for determination of basic clinical tests near the reference intervals. [Original].
- Published
- 2017
185. [Bacteria isolated from surgical infections and its susceptibilities to antimicrobial agents - Special references to bacteria isolated between April 2011 and March 2012].
- Author
-
Shinagawa N, Taniguchi M, Hirata K, Furuhata T, Mizuguchi T, Osanai H, Yanai Y, Hata F, Kihara C, Sasaki K, Oono K, Nakamura M, Shibuya H, Hasegawa I, Kimura M, Watabe K, Hoshikawa T, Oshima H, Aikawa N, Sasaki J, Suzuki M, Sekine K, Abe S, Takeyama H, Wakasugi T, Mashita K, Tanaka M, Mizuno A, Ishikawa M, Iwai A, Saito T, Muramoto M, Kubo S, Lee S, Fukuhara K, Kobayashi Y, Yamaue H, Hirono S, Takesue Y, Fujiwara T, Shinoura S, Kimura H, Iwagaki H, Tokunaga N, Sueda T, Hiyama E, Murakami Y, Ohge H, Uemura K, Tsumura H, Kanehiro T, Takeuchi H, Tanakaya K, and Iwasaki M
- Subjects
- Bacteria drug effects, Microbial Sensitivity Tests, Bacteria isolation & purification, Surgical Wound Infection microbiology
- Abstract
Bacteria isolated from surgical infections during the period from April 2011 to March 2012 were investigated in a multicenter study in Japan, and the following results were obtained. In this series, 785 strains including 31 strains of Candida spp. were isolated from 204 (78.8%) of 259 patients with surgical infections. Five hundred and twenty three strains were isolated from primary infections, and 231 strains were isolated from surgical site infection. From primary infections, anaerobic Gram-negative bacteria were predominant, followed by aerobic Gram-negative bacteria, while from surgical site infection aerobic Gram-positive bacteria were predominant, followed by anaerobic Gram-negative bacteria. Among aerobic Gram-positive bacteria, the isolation rate of Enterococcus spp. was highest, followed by Streptococcus spp. and Staphylococcus spp., in this order, from primary infections, while Enterococcus spp. was highest, followed by Staphylococcus spp. from surgical site infection. Among aerobic Gram-negative bacteria, Escherichia coli was the most predominantly isolated from primary infections, followed by Klebsiella pneumoniae, Pseudomonas aeruginosa and Enterobacter cloacae, in this order, and from surgical site infection, E. coli was most predominantly isolated, followed by P. aeruginosa, K. pneumoniae, and E. cloacae. Among anaerobic Gram-positive bacteria, the isolation rate of Eggerthella lenta was the highest from primary infections, followed by Parvimonas micra, Collinsella aerofaciens, Lactobacillus acidophilus and Finegoldia magna, and from surgical site infection, E. lenta was most predominantly isolated, followed by P micra and L. acidophilus, in this order. Among anaerobic Gram-negative bacteria, the isolation rate of Bacteroidesfragilis was the highest from primary infections, followed by Bilophila wadsworthia, Bacteroides thetaiotaomicron, Bacteroides uniformis and Bacteroides vulgatus, and from surgical site infection, B. fragilis was most predominantly isolated, followed by Bacteroides caccae, B. thetaiotaomicron, Bacteroides ovatus and B. wadsworthia, in this order. In this series, vancomycin-resistant MRSA (methicillin-resistant Staphylococcus aureus), vancomycin-resistant Enterococcus spp. and multidrug-resistant P. aeruginosa were not observed. We should carefully follow up B. wadsworthia which was resistant to various antimicrobial agents, and also Bacteroides spp. which was resistant to many β-lactams.
- Published
- 2014
186. Impact of serum glucose levels on disease severity and outcome in patients with severe sepsis: an analysis from a multicenter, prospective survey of severe sepsis.
- Author
-
Kushimoto S, Gando S, Saitoh D, Mayumi T, Ogura H, Fujishima S, Araki T, Ikeda H, Kotani J, Miki Y, Shiraishi SI, Suzuki K, Suzuki Y, Takeyama N, Takuma K, Tsuruta R, Yamaguchi Y, Yamashita N, and Aikawa N
- Abstract
Aim: To determine whether glycemic abnormality and pre-existing diabetes are associated with disease severity and mortality in patients with severe sepsis., Methods: Six hundred and nineteen patients with severe sepsis were grouped into four categories according to their blood glucose levels (<100, 100-199, 200-299, and ≥300 mg/dL). We compared disease severity and mortality between glycemic categories. In addition, we examined whether there was any relationship with pre-existing diabetes status., Results: There were no significant differences in disseminated intravascular coagulation, Sequential Organ Failure Assessment, or Acute Physiology and Chronic Health Evaluation II scores and mortality rates between patients with or without pre-existing diabetes. However, in patients without pre-existing diabetes, those with blood glucose level <100 mg/dL had higher disseminated intravascular coagulation, Sequential Organ Failure Assessment, and Acute Physiology and Chronic Health Evaluation II scores than those with levels of 100-299 mg/dL. In addition, those with level ≥300 mg/dL had a higher hospital mortality rate than those with levels of 100-199 mg/dL (odds ratio = 4.837). Multivariate logistic regression analysis revealed that a blood glucose level ≥300 mg/dL is an independent predictor of hospital mortality in these patients. In contrast, no significant differences among severity scores or mortality were observed in patients with pre-existing diabetes., Conclusions: In patients with severe sepsis, the impact of glycemic abnormality on disease severity and hospital mortality depends on the pre-existing diabetes status. Specifically, a blood glucose level ≥300 mg/dL may be associated with increased mortality in patients without pre-existing diabetes.
- Published
- 2014
- Full Text
- View/download PDF
187. Penetration of micafungin into the burn eschar in patients with severe burns.
- Author
-
Sasaki J, Yamanouchi S, Sato Y, Abe S, Shinozawa Y, Kishino S, Aikawa N, and Hori S
- Subjects
- Aged, Female, Humans, Male, Micafungin, Middle Aged, Antifungal Agents pharmacokinetics, Burns metabolism, Echinocandins pharmacokinetics, Lipopeptides pharmacokinetics
- Abstract
Micafungin (MCFG) concentrations in the plasma and in burn eschar were investigated after daily intravenous infusion (1 h) of MCFG (200 mg) in three patients with severe burns. MCFG treatment was initiated more than 72 h after the burn injuries. The MCFG concentrations in the plasma were determined at the end of the first administration of MCFG, immediately before the second dosing, at the end of the MCFG infusion after at least 4 days from the initial treatment, and immediately before the subsequent dosing using high-performance liquid chromatography. In addition, the trough levels in burn eschar after both the initial administration and repeated administration were measured. The peak and trough levels in the plasma were comparable to or slightly lower than the reported values in healthy volunteers. The mean (range) MCFG concentrations in the burn eschar after initial administration and repeated administration were 1.41 μg/mL (<0.1-3.98 μg/mL) and 6.65 μg/mL (1.10-14.81 μg/mL), respectively. In most cases, the MCFG concentrations in the burn eschar, especially after repeated administration, were higher than the reported MIC90 of MCFG against the clinically important pathogenic species of Candida and Aspergillus. These results suggest that MCFG is capable of penetrating burn eschar.
- Published
- 2014
- Full Text
- View/download PDF
188. Epidemiology of severe sepsis in Japanese intensive care units: a prospective multicenter study.
- Author
-
Ogura H, Gando S, Saitoh D, Takeyama N, Kushimoto S, Fujishima S, Mayumi T, Araki T, Ikeda H, Kotani J, Miki Y, Shiraishi S, Suzuki K, Suzuki Y, Takuma K, Tsuruta R, Yamaguchi Y, Yamashita N, and Aikawa N
- Subjects
- Aged, Aged, 80 and over, Female, Hospital Mortality, Humans, Intensive Care Units, Japan epidemiology, Male, Middle Aged, Prospective Studies, Sepsis mortality, Survivors statistics & numerical data, Treatment Outcome, Sepsis epidemiology
- Abstract
Severe sepsis is a leading cause of morbidity and mortality in the intensive care unit (ICU). We conducted a prospective multicenter study to evaluate epidemiology and outcome of severe sepsis in Japanese ICUs. The patients were registered at 15 general critical care centers in Japanese tertiary care hospitals when diagnosed as having severe sepsis. Of 14,417 patients, 624 (4.3%) were diagnosed with severe sepsis. Demographic and clinical characteristics at enrollment (Day 1), physiologic and blood variables on Days 1 and 4, and mortality were evaluated. Mean age was 69.0 years, and initial mean Acute Physiology and Chronic Health Evaluation (APACHE) II and Sequential Organ Failure Assessment (SOFA) scores were 23.4 and 8.6, respectively. The 28-day mortality was 23.1%, and overall hospital mortality was 29.5%. SOFA score and disseminated intravascular coagulation (DIC) score were consistently higher in nonsurvivors than survivors on Days 1 and 4. SOFA score, DIC score on Days 1 and 4, and hospital mortality were higher in patients with than without septic shock. SOFA score on Days 1 and 4 and hospital mortality were higher in patients with than without DIC. Logistic regression analyses showed age, presence of septic shock, DIC, and cardiovascular dysfunction at enrollment to be predictors of 28-day mortality and presence of comorbidity to be an additional predictor of hospital mortality. Presence of septic shock or DIC resulted in approximately twice the mortality of patients without each factor, whereas the presence of comorbidity may be a significant predictor of delayed mortality in severe sepsis., (Copyright © 2013 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
189. A multicenter, prospective evaluation of quality of care and mortality in Japan based on the Surviving Sepsis Campaign guidelines.
- Author
-
Fujishima S, Gando S, Saitoh D, Mayumi T, Kushimoto S, Shiraishi S, Ogura H, Takuma K, Kotani J, Ikeda H, Yamashita N, Suzuki K, Tsuruta R, Takeyama N, Araki T, Suzuki Y, Miki Y, Yamaguchi Y, and Aikawa N
- Subjects
- Hospital Mortality, Humans, Intensive Care Units, Japan epidemiology, Prospective Studies, Quality of Health Care, Sepsis epidemiology, Sepsis therapy, Shock, Septic epidemiology, Shock, Septic therapy, Sepsis mortality, Shock, Septic mortality
- Abstract
To elucidate the standard Surviving Sepsis Campaign (SSC) guidelines-based quality of care and mortality related to severe sepsis in Japan, we conducted a multicenter, prospective, observational study using a new web-based database between June 1, 2010, and December 31, 2011. A total of 1104 patients with severe sepsis were enrolled from 39 Japanese emergency and critical care centers. All-cause hospital mortality was 29.3% in patients with severe sepsis and 40.7% in patients with septic shock. Pulmonary, renal, hepatic, and hematological dysfunctions were associated with significantly higher mortality, and hematological dysfunction, especially coagulopathy, was associated with the highest odds ratio for mortality. Compliance with severe sepsis bundles in our study was generally low compared with that in a previous international sepsis registry study, and glycemic control was associated with lowest odds ratio for mortality. Despite higher complication rates of multiple organ dysfunction syndrome and low compliance with severe sepsis bundles on the whole, mortality in our study was similar to that in the international sepsis registry study. From these results, we concluded that our prospective multicenter study was successful in evaluating SSC guidelines-based standard quality of care and mortality related to severe sepsis in Japan. Although mortality in Japan was equivalent to that reported worldwide in the above-mentioned international sepsis registry study, compliance with severe sepsis bundles was low. Thus, there is scope for improvement in the initial treatment of severe sepsis and septic shock in Japanese emergency and critical care centers., (Copyright © 2013 Japanese Society of Chemotherapy and the Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
190. A Phase II study of polyclonal anti-TNF-α (AZD9773) in Japanese patients with severe sepsis and/or septic shock.
- Author
-
Aikawa N, Takahashi T, Fujimi S, Yokoyama T, Yoshihara K, Ikeda T, Sadamitsu D, Momozawa M, and Maruyama T
- Subjects
- Aged, Aged, 80 and over, Anti-Inflammatory Agents adverse effects, Anti-Inflammatory Agents pharmacokinetics, Double-Blind Method, Female, Humans, Immunoglobulin Fab Fragments adverse effects, Immunoglobulin Fab Fragments metabolism, Interleukins blood, Japan, Male, Middle Aged, Multiple Organ Failure, Sepsis blood, Sepsis metabolism, Shock, Septic blood, Shock, Septic metabolism, Tumor Necrosis Factor-alpha blood, Anti-Inflammatory Agents therapeutic use, Immunoglobulin Fab Fragments therapeutic use, Sepsis drug therapy, Shock, Septic drug therapy, Tumor Necrosis Factor-alpha antagonists & inhibitors
- Abstract
Because tumor necrosis factor-alpha (TNF-α) induces many of the pathophysiological signs and symptoms observed in sepsis, it is a potential therapeutic target for treatment. The primary objective of this study was to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of single and multiple intravenous (i.v.) infusions of two doses of AZD9773 in Japanese patients with severe sepsis and/or septic shock. In this Phase II, double-blind, placebo-controlled, dose-escalation study (ClinicalTrials.gov Identifier: NCT01144624), Japanese patients were randomized to two successive treatment cohorts (cohort 1, loading/maintenance doses of 250/50 U/kg or placebo; cohort 2, loading/maintenance doses of 500/100 U/kg or placebo) for a 5-day treatment period, then a follow-up period to day 29. Twenty patients were enrolled (AZD9773 cohort 1, n = 7; AZD9773 cohort 2, n = 7; placebo, n = 6), and all completed the study. Most treatment-emergent adverse events (TEAEs) were mild or moderate and none led to discontinuation. The most common TEAEs in the AZD9773 cohorts were pleural effusion (64.3%) and peripheral edema (28.6%). Pharmacokinetic data demonstrated an approximately proportional increase in concentration with increasing dose. Treatment with AZD9773 led to a decrease in TNF-α concentrations, which was more discernible in the AZD9773 cohort 2; TNF-α concentrations generally decreased with time in patients receiving placebo. A similar pattern of response was observed with interleukin-6 (IL-6) and IL-8. AZD9773 was generally well tolerated with dose-proportional pharmacokinetics in Japanese patients with severe sepsis/septic shock.
- Published
- 2013
- Full Text
- View/download PDF
191. Efficacy and safety of intravenous daptomycin in Japanese patients with skin and soft tissue infections.
- Author
-
Aikawa N, Kusachi S, Mikamo H, Takesue Y, Watanabe S, Tanaka Y, Morita A, Tsumori K, Kato Y, and Yoshinari T
- Subjects
- Adult, Aged, Aged, 80 and over, Anti-Bacterial Agents pharmacokinetics, Creatinine blood, Creatinine metabolism, Daptomycin pharmacokinetics, Female, Humans, Kidney Function Tests, Male, Methicillin-Resistant Staphylococcus aureus drug effects, Microbial Sensitivity Tests, Middle Aged, Soft Tissue Infections metabolism, Soft Tissue Infections microbiology, Staphylococcal Skin Infections metabolism, Staphylococcal Skin Infections microbiology, Vancomycin therapeutic use, Anti-Bacterial Agents adverse effects, Anti-Bacterial Agents therapeutic use, Daptomycin adverse effects, Daptomycin therapeutic use, Soft Tissue Infections drug therapy, Staphylococcal Skin Infections drug therapy
- Abstract
Daptomycin is a lipopeptide antibiotic active against gram-positive organisms and recently approved for marketing in Japan. This study investigates the efficacy and safety of daptomycin in Japanese patients with skin and soft tissue infections (SSTIs) caused by methicillin-resistant Staphylococcus aureus (MRSA) for regulatory filing in Japan. Overall, 111 Japanese patients with SSTI were randomized in this open-label, randomized, active-comparator controlled, parallel-group, multicenter, phase III study. Patients received intravenous daptomycin 4 mg/kg once daily or vancomycin 1 g twice daily for 7-14 days. Efficacy was determined by a blinded Efficacy Adjudication Committee. Among patients with SSTIs caused by MRSA, 81.8 % (95 % CI, 69.1-90.9) of daptomycin recipients and 84.2 % (95 % CI, 60.4-96.6) of vancomycin recipients achieved a successful clinical response at the test-of-cure (TOC) visit. The microbiological success rate against MRSA at the TOC visit was 56.4 % (95 % CI, 42.3-69.7) with daptomycin and 47.4 % (95 % CI, 24.4-71.1) with vancomycin. Daptomycin was generally well tolerated; most adverse events were of mild to moderate severity. The measurement of daptomycin concentration in plasma revealed that patients with mild or moderate impaired renal function showed similar pharmacokinetics profiles to patients with normal renal function. Clinical and microbiological responses, stratified by baseline MRSA susceptibility, suggested that patients infected with MRSA of higher daptomycin MIC showed a trend of lower clinical success with a P value of 0.052 by Cochran-Armitage test. Daptomycin was clinically and microbiologically effective for the treatment of MRSA-associated SSTIs in Japanese patients.
- Published
- 2013
- Full Text
- View/download PDF
192. Brown adipose tissue and its modulation by a mitochondria-targeted peptide in rat burn injury-induced hypermetabolism.
- Author
-
Yo K, Yu YM, Zhao G, Bonab AA, Aikawa N, Tompkins RG, and Fischman AJ
- Subjects
- Adipose Tissue, Brown metabolism, Adipose Tissue, Brown ultrastructure, Animals, Burns metabolism, Burns pathology, Burns physiopathology, Down-Regulation drug effects, Energy Metabolism drug effects, Ion Channels antagonists & inhibitors, Male, Microscopy, Electron, Transmission, Mitochondria metabolism, Mitochondria ultrastructure, Mitochondrial Diseases etiology, Mitochondrial Proteins antagonists & inhibitors, Mitochondrial Turnover drug effects, Molecular Targeted Therapy, Random Allocation, Rats, Rats, Sprague-Dawley, Scapula, Specific Pathogen-Free Organisms, Uncoupling Protein 1, Up-Regulation drug effects, Adipose Tissue, Brown drug effects, Burns drug therapy, Free Radical Scavengers therapeutic use, Ion Channels metabolism, Mitochondria drug effects, Mitochondrial Diseases prevention & control, Mitochondrial Proteins metabolism, Oligopeptides therapeutic use
- Abstract
Hypermetabolism is a prominent feature of burn injury, and altered mitochondria function is presumed to contribute to this state. Recently, brown adipose tissue (BAT) was found to be present not only in rodents but also in humans, and its activity is associated with resting metabolic rate. In this report, we elucidate the relationship between burn injury-induced hypermetabolism and BAT activity and the possible role of the mitochondria-targeted peptide SS31 in attenuating burn injury-induced hypermetabolism by using a rat burn injury model. We demonstrate that burn injury induces morphological changes in interscapular BAT (iBAT). Burn injury was associated with iBAT activation, and this effect was positively correlated with increased energy expenditure. BAT activation was associated with augmentation of mitochondria biogenesis, and UCP1 expression in the isolated iBAT mitochondria. In addition, the mitochondria-targeted peptide SS31 attenuated burn injury-induced hypermetabolism, which was accompanied by suppression of UCP1 expression in isolated mitochondria. Our results suggest that BAT plays an important role in burn injury-induced hypermetabolism through its morphological changes and expression of UCP1.
- Published
- 2013
- Full Text
- View/download PDF
193. Micafungin concentrations in the plasma and burn eschar of severely burned patients.
- Author
-
Sasaki J, Yamanouchi S, Kudo D, Endo T, Nomura R, Takuma K, Kushimoto S, Shinozawa Y, Kishino S, Hori S, and Aikawa N
- Subjects
- Adult, Aged, 80 and over, Antifungal Agents administration & dosage, Burns complications, Burns metabolism, Echinocandins administration & dosage, Female, Humans, Lipopeptides administration & dosage, Male, Micafungin, Middle Aged, Mycoses microbiology, Young Adult, Antifungal Agents blood, Antifungal Agents pharmacokinetics, Burns drug therapy, Echinocandins blood, Echinocandins pharmacokinetics, Lipopeptides blood, Lipopeptides pharmacokinetics, Mycoses drug therapy
- Abstract
Micafungin concentrations in plasma and burn eschar after daily intravenous infusion (1 h) of micafungin (200 to 300 mg) were investigated for six patients with severe burns. Micafungin treatment was initiated more than 72 h after the burn injuries. The peak and trough levels in the plasma after the initial administration and repeated administrations for more than 4 days were comparable with or slightly lower than the reported values for healthy volunteers. Micafungin concentrations in the plasma and burn eschar were between 3.6 and >1,000 times higher than the reported MIC(90)s of micafungin against clinically important Candida and Aspergillus species.
- Published
- 2012
- Full Text
- View/download PDF
194. Reevaluation of the efficacy and safety of the neutrophil elastase inhibitor, Sivelestat, for the treatment of acute lung injury associated with systemic inflammatory response syndrome; a phase IV study.
- Author
-
Aikawa N, Ishizaka A, Hirasawa H, Shimazaki S, Yamamoto Y, Sugimoto H, Shinozaki M, Taenaka N, Endo S, Ikeda T, and Kawasaki Y
- Subjects
- Acute Lung Injury physiopathology, Aged, Aged, 80 and over, Female, Glycine adverse effects, Glycine pharmacology, Humans, Infusions, Intravenous, Male, Middle Aged, Proteinase Inhibitory Proteins, Secretory adverse effects, Proteinase Inhibitory Proteins, Secretory pharmacology, Respiration, Artificial, Serine Proteinase Inhibitors adverse effects, Sulfonamides adverse effects, Survival Rate, Systemic Inflammatory Response Syndrome physiopathology, Ventilator Weaning, Acute Lung Injury drug therapy, Glycine analogs & derivatives, Serine Proteinase Inhibitors pharmacology, Sulfonamides pharmacology, Systemic Inflammatory Response Syndrome drug therapy
- Abstract
Introduction: Sivelestat, a neutrophil elastase inhibitor, has been approved in Japan for the treatment of patients with acute lung injury (ALI) associated with systemic inflammatory response syndrome (SIRS). The Pharmaceuticals and Medical Devices Agency (PMDA) has ordered to conduct a postmarket clinical study in order to reevaluate the efficacy and safety of Sivelestat in actual clinical settings in Japan., Methods: According to the PMDA's order, we evaluated the efficacy and safety of Sivelestat in Japanese patients with ALI associated with SIRS using ventilator-free days (VFD) as the primary endpoint. The surrogate endpoints are ventilator-weaning rate, ICU discharge rate, and 180-day survival rate. Study design was an open-label, non-randomized, multi-center clinical trial. Sivelestat was intravenously administered at 0.2 mg/kg/h continuously for a maximum of 14 days. Sivelestat group and control group were compared by adjusting the outcome values using an inverse probability of treatment weighted method based on the propensity scores., Results: Four hundred and four Sivelestat group patients and 177 control group patients were enrolled. The adjusted mean number of VFD was 15.7 and 12.1 in the Sivelestat group and control group, respectively (P = 0.0022). Both the adjusted ventilator-weaning rate and ICU discharge rate were significantly higher in the Sivelestat group than in the control group (P = 0.0028 and P = 0.019, respectively). The adjusted 180-day survival rate was significantly higher in the Sivelestat group than in the control group (71.8 percent vs. 56.3 percent)., Conclusions: Sivelestat contributed to early weaning from the mechanical ventilation, while showing no negative effect on the long-term outcomes of ALI associated with SIRS. The results of this study suggest the clinical usefulness of Sivelestat in this patient population., (Copyright © 2011 Elsevier Ltd. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF
195. [Bacteria isolated from surgical infections and its susceptibilities to antimicrobial agents--special references to bacteria isolated between April 2009 and March 2010].
- Author
-
Shinagawa N, Osanai H, Hirata K, Furuhata T, Mizukuchi T, Yanai Y, Hata F, Taniguchi M, Sasaki K, Someya T, Sasaki K, Oono K, Mizuno I, Shamoto T, Fukui T, Tokita S, Nakamura M, Mashita K, Shibuya H, Tanaka M, Hasegawa I, Kimura M, Oshima H, Maeda H, Ishikawa S, Mukaiya M, Kihara C, Mizuno A, Watabe K, Iwai A, Saito T, Hoshikawa T, Kimura H, Moori N, Sumita N, Jae-Hoon Y, Kubo S, Lee S, Aikawa N, Sekine K, Abe S, Oomura T, Takeyama H, Wakasugi T, Kobayashi Y, Tsuji T, Yamaue H, Ozawa S, Takesue Y, Fujiwara T, Tsumura H, Kimura H, Yokoyama T, Iwagaki H, Takeuchi H, Tanakaya K, Sueda T, Hiyama E, Murakami Y, Ohge H, Uemura K, Yasunami Y, and Sasaki T
- Subjects
- Drug Resistance, Bacterial, Humans, Seasons, Time Factors, Anti-Bacterial Agents pharmacology, Bacteria drug effects, Bacteria isolation & purification, Surgical Wound Infection microbiology
- Abstract
Bacteria isolated from surgical infections during the period from April 2009 to March 2010 were investigated in a multicenter study in Japan, and the following results were obtained. In this series, 671 strains including 16 strains of Candida spp. were isolated from 174 (79.1%) of 220 patients with surgical infections. Four hundred and eleven strains were isolated from primary infections, and 244 strains were isolated from surgical site infection. From primary infections, anaerobic Gram-negative bacteria were predominant, followed by aerobic Gram-negative bacteria, while from surgical site infection aerobic Gram-positive bacteria were predominant, followed by anaerobic Gram-negative bacteria. Among aerobic Gram-positive bacteria, the isolation rate of Enterococcus spp. was highest, followed by Streptococcus spp., and Staphylococcus spp. in this order, from primary infections, while Enterococcus spp. was highest, followed by Staphylococcus spp. from surgical site infection. Among aerobic Gram-negative bacteria, Escherichia coli was the most predominantly isolated from primary infections, followed by Klebsiella pneumoniae, Enterobacter cloacae and Pseudomonas aeruginosa, in this order, and from surgical site infection, E. coli was most predominantly isolated, followed by P. aeruginosa and E. cloacae. Among anaerobic Gram-positive bacteria, the isolation rate of Eggerthella lenta was the highest from primary infections, followed by Parvimonas micra, Streptococcus constellatus and Finegoldia magna, and from surgical site infection, E. lenta was most predominantly isolated. Among anaerobic Gram-negative bacteria, the isolation rate of Bilophila wadsworthia was the highest from primary infections, followed by Bacteroides fragilis, Bacteroides ovatus and Bacteroides thetaiotaomicron, and from surgical site infection, B. fragilis was most predominantly isolated, followed by B. ovatus, B. wadsworthia and B. thetaiotaomicron, in this order. In this series, we noticed no vancomycin-resistant Gram-positive cocci, nor multidrug-resistant P. aeruginosa. We should carefully follow up B. wadsworthia which was resistant to various antibiotics, and also Bacteroides spp. which was resistant to many beta-lactam antibiotics.
- Published
- 2011
196. The role of a real-time PCR technology for rapid detection and identification of bacterial and fungal pathogens in whole-blood samples.
- Author
-
Obara H, Aikawa N, Hasegawa N, Hori S, Ikeda Y, Kobayashi Y, Murata M, Okamoto S, Takeda J, Tanabe M, Sakakura Y, Ginba H, Kitajima M, and Kitagawa Y
- Subjects
- Bacteria genetics, Female, Fungi genetics, Humans, Male, Middle Aged, Sensitivity and Specificity, Sepsis blood, Sepsis microbiology, Systemic Inflammatory Response Syndrome blood, Systemic Inflammatory Response Syndrome microbiology, Bacteria isolation & purification, Bacterial Infections blood, Blood microbiology, Fungi isolation & purification, Mycoses blood, Polymerase Chain Reaction methods
- Abstract
The rapid diagnosis of pathogens and prompt initiation of appropriate antibiotic therapy are critical factors to reduce the morbidity and mortality associated with sepsis. In this study, we evaluated a multiplex polymerase chain reaction (PCR-M) test that detects bacteria and fungi in whole-blood specimens, comparing its features to those of a blood culture (BC). Following evaluation of the performance for sensitivity and specificity of PCR-M, 78 blood samples from 54 patients with suspected bacterial infections were evaluated. Whole-blood samples for PCR-M were collected at the same time as BC, and PCR-M results were compared with BC results. As a result, minimum sensitivity of the kit was 1-100 cfu/ml. The PCR-M test correctly identified specificity for 13 out of 14 strains blinded to the assay analyst. Of 78 blood samples examined, 56 (72%) were negative by both methods, and 22 (28%) were positive by at least one of the two methods. PCR-M detected organisms in 21 cases (27%) compared with 12 cases (15%) in BC. The correlation of positives between PCR-M and BC was 92% (11/12), and both methods identified the same organisms in these 11 cases. With higher positive rate compared with BC, PCR-M could detect and identify potentially significant microorganisms within a few hours by using a small volume of a single whole-blood sample. Early detection of microorganisms has the potential to facilitate early determination of appropriate treatment and antimicrobial selection.
- Published
- 2011
- Full Text
- View/download PDF
197. [Revised Surviving Sepsis Campaign Guidelines and therapy for severe sepsis].
- Author
-
Aikawa N
- Subjects
- Antifungal Agents administration & dosage, Candidiasis complications, Candidiasis drug therapy, Cytokines blood, Disseminated Intravascular Coagulation, Humans, Multiple Organ Failure, Sepsis complications, Severity of Illness Index, Shock, Septic, Systemic Inflammatory Response Syndrome, Practice Guidelines as Topic, Sepsis drug therapy
- Published
- 2011
198. [Bacteria isolated from surgical infections and their susceptibilities to antimicrobial agents --special references to bacteria isolated between April 2008 and March 2009].
- Author
-
Shinagawa N, Hasegawa M, Hirata K, Furuhata T, Mizukuchi T, Osanai H, Yanai Y, Hata F, Sasaki K, Someya T, Harada K, Oono K, Tokita S, Nakamura M, Shibuya H, Hasegawa I, Kimura M, Oshima H, Maeda H, Mukaiya M, Kihara C, Kosho W, Hoshikawa T, Kimura H, Ushijima Y, Yae-Hoon Y, Aikawa N, Abe S, Yura J, Takeyama H, Wakasugi T, Taniguchi M, Mizuno I, Fukui T, Mashita K, Ishikawa S, Mizuno A, Moori N, Sumita N, Kubo S, Lee S, Oomura T, Kobayashi Y, Tsuji T, Yamaue H, Kawai M, Takesue Y, Tanaka N, Kimura H, Iwagaki H, Sueda T, Hiyama E, Murakami Y, Ooge H, Uemura K, Tsumura H, Yokoyama T, Takeuchi H, Tanakaya K, Yasunami Y, and Ryu S
- Subjects
- Digestive System Surgical Procedures, Drug Resistance, Bacterial, Humans, Japan, Time Factors, Anti-Bacterial Agents pharmacology, Gram-Negative Aerobic Bacteria drug effects, Gram-Negative Aerobic Bacteria isolation & purification, Gram-Negative Anaerobic Bacteria drug effects, Gram-Negative Anaerobic Bacteria isolation & purification, Gram-Positive Bacteria drug effects, Gram-Positive Bacteria isolation & purification, Surgical Wound Infection microbiology
- Abstract
Bacteria isolated from infections in abdominal surgery during the period from April 2008 to March 2009 were investigated in a multicenter study in Japan, and the following results were obtained. In this series, 712 strains including 18 strains of Candida spp. were isolated from 173 (80.5%) of 215 patients with surgical infections. Three hundred and sixty-six strains were isolated from primary infections, and 346 strains were isolated from postoperative infections. From primary infections, anaerobic Gram-negative bacteria were predominant, followed by aerobic Gram-negative bacteria, while from postoperative infections aerobic Gram-positive bacteria were predominant, followed by anaerobic Gram-negative bacteria. Among aerobic Gram-positive bacteria, the isolation rate of Enterococcus spp. was highest, followed by Streptococcus spp., and Staphylococcus spp. in this order, from primary infections, while Enterococcus spp. was highest, followed by Staphylococcus spp. from postoperative infections. Among aerobic Gram-negative bacteria, Escherichia coli was the most predominantly isolated from primary infections, followed by Klebsiella pneumoniae and Pseudomonas aeruginosa, in this order, and from postoperative infections, P aeruginosa was most predominantly isolated, followed by E. coli, Enterobacter cloacae, and K. pneumoniae. Among anaerobic Gram-positive bacteria, the isolation rate of Eggerthella lenta was the highest from primary infections, followed by Parvimonas micra, Streptococcus constellatus and Gemella morbillorum, and from postoperative infections, E. lenta was most predominantly isolated. Among anaerobic Gram-negative bacteria, the isolation rate of Bacteroides fragilis was the highest from primary infections, followed by Bacteroides thetaiotaomicron, Bacteroides ovatus and Bilophila wadsworthia, and from postoperative infections, B. fragilis was most predominantly isolated, followed by B. thetaiotaomicron, B. wadsworthia and B. ovatus, in this order. In this series, we noticed no vancomycin-resistant methicillin-resistant S. aureus, and Enterococcus spp., nor multidrug-resistant P aeruginosa. We should carefully follow up B. wadsworthia which was resistant to various antibiotics, and also Bacteroides spp. which was resistant to many beta-lactam antibiotics.
- Published
- 2010
199. [Bacteria isolated from surgical infections and their susceptibility to antimicrobial agents--special reference to bacteria isolated between April 2007 and March 2008].
- Author
-
Shinagawa N, Hasegawa M, Hirata K, Katsuramaki T, Mizukuchi T, Ushijima Y, Ushida T, Aikawa N, Yo K, Yura J, Takeyama H, Wakasugi T, Taniguchi M, Mizuno I, Mashita K, Ishikawa S, Mizuno A, Tsumura H, Yokoyama T, Moori N, Sumita N, Kubo S, Lee S, Oomura T, Kobayashi Y, Tsuji T, Yamaue H, Kawai M, Takesue Y, Tanaka N, Kimura H, Iwagaki H, Sueda T, Hiyama E, Murakami Y, Ooge H, Uemura K, Takeuchi H, Yasui Y, Yasunami Y, and Ryu S
- Subjects
- Drug Resistance, Bacterial, Humans, Time Factors, Anti-Bacterial Agents pharmacology, Bacteria drug effects, Bacteria isolation & purification, Bacterial Infections microbiology, Postoperative Complications microbiology, Surgical Wound Infection microbiology
- Abstract
Bacteria isolated from infections in abdominal surgery during the period from April 2007 to March 2008 were investigated in a multicenter study in Japan, and the following results were obtained. In this series, 707 strains including 24 strains of Candida spp. were isolated from 181 (79.0%) of 229 patients with surgical infections. Three hundred and ninety-five strains were isolated from primary infections, and 288 strains were isolated from postoperative infections. From primary infections, anaerobic Gram-negative bacteria were predominant, followed by aerobic Gram-negative bacteria, while from postoperative infections aerobic Gram-positive bacteria were predominant, followed by anaerobic Gram-negative bacteria. Among aerobic Gram-positive bacteria, the isolation rate of Enterococcus spp. was highest, followed by Streptococcus spp., and Staphylococcus spp. in this order, from primary infections, while Enterococcus spp. was highest, followed by Staphylococcus spp. from postoperative infections. Among aerobic Gram-negative bacteria, Escherichia coli was the most predominantly isolated from primary infections, followed by Klebsiella pneumoniae, Pseudomonas aeruginosa and Enterobacter cloacae, in this order, and from postoperative infections, P. aeruginosa was most predominantly isolated, followed by E. cloacae, E. coli and K. pneumoniae. Among anaerobic Gram-positive bacteria, the isolation rate of Parvimonas micra was the highest from primary infections, followed by Streptococcus constellatus and Gemella morbillorum, and from postoperative infections, Anaerococcus prevotii was most predominantly isolated. Among anaerobic Gram-negative bacteria, the isolation rate of both Bacteroides fragilis and Bilophila wadsworthia were the highest from primary infections, followed by Bacteroides thetaiotaomicron and Campylobacter gracilis, and from postoperative infections, B. thetaiotaomicron was most predominately isolated, followed by B. fragilis, Bacteroides caccae and B. wadsworthia in this order. In this series, we noticed no vancomycin-resistant Gram-positive cocci, nor multidrug-resistant P aeruginosa. There were nine strains of coagulase-negative Staphylococci which show higher MIC against teicoplanin more than 4 gg/mL, but all of them had good susceptibilities against various anti-MRSA antibiotics. We should carefully follow up B. wadsworthia which was resistant to various antibiotics, and also Bacteroides spp. which was resistant to many beta-lactam antibiotics.
- Published
- 2009
200. Clinical effects of micafungin, a novel echinocandin antifungal agent, on systemic fungal infections in surgery, emergency, and intensive-care medicine: evaluation using the AKOTT algorithm.
- Author
-
Aikawa N, Kusachi S, Oda S, Takesue Y, and Tanaka H
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Algorithms, Antifungal Agents adverse effects, Child, Child, Preschool, Drug Eruptions etiology, Echinocandins adverse effects, Emergency Service, Hospital, Female, Humans, Intensive Care Units, Japan, Lipopeptides adverse effects, Liver Diseases etiology, Male, Micafungin, Middle Aged, Postoperative Complications microbiology, Product Surveillance, Postmarketing, Treatment Outcome, Antifungal Agents therapeutic use, Aspergillosis drug therapy, Candidiasis drug therapy, Echinocandins therapeutic use, Lipopeptides therapeutic use, Postoperative Complications drug therapy
- Abstract
The clinical efficacy of micafungin (MCFG) in surgery, emergency, and intensive-care medicine has been studied in only a limited number of cases. We conducted a multicenter postmarketing study to evaluate MCFG efficacy and safety in Japan. MCFG was given to patients with a temperature exceeding 37.5 degrees C, either with a proven fungal infection based on mycological or histopathological examination, or those who were regarded as having probable or possible fungal infections (patients who had at least one high-risk factor for the development of a systemic fungal infection and for whom fungi had been detected at multiple sites by surveillance culture or a positive beta-D-glucan test). Efficacy was evaluated using the AKOTT algorithm created by our group (AKOTT is an acronym created from the first letter of the surname of each of the five members of the evaluation committee). Of the 180 patients enrolled, 68 were excluded by exclusion criteria or for other reasons, and 112 (58 with proven candidiasis, 1 with proven aspergillosis, and 53 with suspected fungal infection) were evaluated for efficacy. MCFG was administered at a mean daily dose of 104 mg for a mean duration of 14.2 days. It was effective in 72 p 72 patients, ineffective in 28, and the effect was undeterminable in 12, for an overall clinical efficacy 72.0%. MCFG was effective in 78.6% of those with proven candidiasis and in 65.1% with suspected fungal infection, but it was ineffective in the 1 patient with aspergillosis. MCFG eradicated 77.6% (52/67) of fungi isolated. There were 69 drug-related adverse reactions, mainly abnormal hepatic function tests, in 37 of 178 patients evaluated for safety. One adverse reaction, skin eruption, had a probable causal relationship with drug treatment. In conclusion, MCFG had high clinical efficacy and safety in the treatment of deep-seated fungal infections in surgery, emergency, and intensive-care medicine, indicating good potential as a firstline drug for both targeted and empirical therapies.
- Published
- 2009
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.